Trinity Biotech PLC ADR TRIB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $0.66
- Day Range
- $0.67–0.71
- 52-Week Range
- $0.50–3.44
- Bid/Ask
- $0.60 / $0.69
- Shares Outstanding
- 20.25M
- Market Cap
- $13.92M
- Volume/Avg
- 106,271 / 152,616
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.37
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 287
- Website
- https://www.trinitybiotech.com
Valuation
|
Metric
|
TRIB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.37 |
Price/Cash Flow | — |
Price/Earnings
TRIB
Financial Strength
|
Metric
|
TRIB
|
|---|---|
Quick Ratio | 0.11 |
Current Ratio | 0.25 |
Interest Coverage | −1.85 |
Quick Ratio
TRIB
Profitability
|
Metric
|
TRIB
|
|---|---|
Return on Assets (Normalized) | −24.18% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −20.89% |
Return on Assets
TRIB
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Khsdgdhz | Nvwbc | $159B | |||
| Stryker Corp
SYK
| Zbkggdpnbd | Ppfbt | $120B | |||
| Medtronic PLC
MDT
| Gkdxwscg | Rgtwdq | $103B | |||
| Boston Scientific Corp
BSX
| Lznmmcdp | Wpdscq | $72B | |||
| Edwards Lifesciences Corp
EW
| Zsbdtzgb | Qzkwjx | $50B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Xsbyllyj | Tnnzl | $29B | |||
| DexCom Inc
DXCM
| Fjzznzml | Fqfhd | $29B | |||
| Koninklijke Philips NV ADR
PHG
| Bkc | Hqg | $26B | |||
| Steris PLC
STE
| Gnhxnzts | Hyfwg | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Fcpjzcmwnp | Smd | $17B |
United States